Gottlieb, AB, P Gisondi, J Eells, L Peterson, and A Kavanaugh. “Durability of Response in Patients With Psoriatic Arthritis Treated With Certolizumab Pegol over 216 Weeks: Post-Hoc Analyses from the RAPID-PsA Study”. SKIN The Journal of Cutaneous Medicine 4, no. 1 (January 28, 2020): S2. Accessed July 3, 2024. https://jofskin.org/33014/index.php/skin/article/view/801.